Literature DB >> 15118677

Src kinases in Ph+ lymphoblastic leukemia.

Michael Deininger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15118677     DOI： 10.1038/ng0504-440

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  5 in total

Review 1.  Src kinase signaling in leukaemia.

Authors:  Shaoguang Li
Journal:  Int J Biochem Cell Biol       Date:  2007-02-09       Impact factor: 5.085

2.  BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance.

Authors:  Hilmar Quentmeier; Sonja Eberth; Julia Romani; Margarete Zaborski; Hans G Drexler
Journal:  J Hematol Oncol       Date:  2011-02-07       Impact factor: 17.388

3.  Determinant of factors associated with child health outcomes and service utilization in Ghana: multiple indicator cluster survey conducted in 2011.

Authors:  Duah Dwumoh; Edward Eyipe Essuman; Seth Kwaku Afagbedzi
Journal:  Arch Public Health       Date:  2014-12-01

Review 4.  Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors.

Authors:  Shaoguang Li; Dongguang Li
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

5.  GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways.

Authors:  Wei Ye; Zhiwu Jiang; Xiaoyun Lu; Xiaomei Ren; Manman Deng; Shouheng Lin; Yiren Xiao; Simiao Lin; Suna Wang; Baiheng Li; Yi Zheng; Peilong Lai; Jianyu Weng; Donghai Wu; Yuguo Ma; Xudong Chen; Zhesheng Wen; Yaoyu Chen; Xiaoyan Feng; Yangqiu Li; Pentao Liu; Xin Du; Duanqing Pei; Yao Yao; Bing Xu; Ke Ding; Peng Li
Journal:  Oncotarget       Date:  2016-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.